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Chronic cough has been suggested to be due to three conditions, asthma, post nasal drip, and reflux disease. A
different paradigm has evolved in which cough is viewed as the primary condition characterised by afferent
neuronal hypersensitivity and different aspects of this syndrome are manifest in the different phenotypes of cough.
There are several advantages to viewing cough hypersensitivity as the unifying diagnosis; Communication with
patients is aided, aetiology is not restricted and therapeutic avenues opened. Cough Hypersensitivity Syndrome is a
more applicable label to embrace the clinical manifestations of this disabling disease.Introduction
Our continuing difficulty in dealing with patients pre-
senting with chronic cough is an example of an
established dogma failing to measure up to awkward
clinical facts. In the 1980s patients presenting with iso-
lated chronic cough were suggested to fall into one of
three diagnostic categories. Indeed, this hypothesis was
crystallised into ‘the diagnostic triad of cough’ [1].
Cough was either due to a form of asthma, gastroesoph-
ageal reflux disease, or a nebulous and poorly defined
condition variously called, Post Nasal Drip Syndrome or
the Upper Airways Cough Syndrome [2]. Unfortunately,
for those promulgating this paradigm patients presenting
to the clinic often failed to fit into these diagnostic
categories. The term idiopathic cough was duly coined
to overcome the difficulties arising from the failure to
pigeonhole such awkward patients [3].
To many working in the field this classification was
deeply unsatisfactory. Firstly, when one of the three
diagnostic labels was attached to a patient further inves-
tigation frequently revealed a grossly atypical pattern of
disease. Thus, patients with ‘asthmatic cough’ sometimes
did not wheeze, a symptom most would regard as sine
qua non of asthma. These patients with cough variant or
cough predominant asthma were suggested to have a
differential location of the inflammation within the air-
way. However, an even more bizarre form of ‘asthma’,
known as eosinophilic bronchitis, was also clearly a
significant cause of cough in the clinic [4]. Here there isCorrespondence: a.h.morice@hull.ac.uk
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reproduction in any medium, provided the orno bronchial hyperresponsiveness but evidence, usually
obtained at induced sputum, of eosinophilic inflamma-
tion within the airways. Is this a form of asthma? Some
would suggest that this is a separate condition. In the
clinic however patients frequently straddle diagnostic
boundaries and the further description of subtypes
expands the numbers of “diseases” causing cough.
Secondly, there are patients whose predominant symp-
tom is cough but clearly have conditions which are a
recognised illness, such as pulmonary fibrosis due to
interstitial lung disease or non cystic fibrosis bronchiec-
tasis. In some patients their chronic cough, on detailed
history, is virtually identical in nature and in associated
features to the cough seen in patients with other forms
of chronic cough [5]. Does the illness cause the cough or
is the cough (through its underlying aetiology) actually
the cause of the illness?
In an attempt to clarify this state of affairs the concept
arose that the similarities in the clinical features of
patients presenting with a chronic cough outweighed the
differences. Thus, cough became to be viewed in a com-
pletely different paradigm. In the majority of patients
with chronic cough it was suggested that there were not
a series of individual diseases leading to the symptom
but it was rather that there was a single underlying con-
dition, chronic cough, which gave rise to a variety of dif-
ferent phenotypes. Since virtually all patients exhibit a
hypersensitivity of the cough reflex the term Cough
Hypersensitivity Syndrome was coined as an overarching
diagnostic label [6,7]. As with any attempt to character-
ise and codify the clinical world the Cough Hypersensi-
tivity Syndrome does have a number of drawbacks [8].
However, the greater understanding of the diagnosis andhis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Capsaicin dose response curve on captopril (squares)
or placebo (circles). Leftward shift indicates an increased cough
sensitivity on ACE inhibitor.
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sights into the epidemiology, management and potential
future developments have established Cough Hypersensi-
tivity as the most accurate and convenient diagnostic
grouping for patients suffering with chronic cough. In the
clinic adopting the approach of establishing the Cough
Hypersensitivity Syndrome as the primary diagnosis and
then recognising the different phenotypes of allergic upper
and lower airway inflammation and in the majority non
allergic inflammatory change provides lucidity in both
management and therapy.
Evidence for cough hypersensitivity
That hypersensitivity of the cough reflex occurs during
an upper respiratory tract infection is a universal experi-
ence. During a cough/cold we all experience bouts of
coughing as the result of minor environment insults,
such as change in temperature or exposure to noxious
stimuli like cigarette smoke. Objective evidence of this
hypersensitivity relies on challenge experiments. A shift
in the cough dose response curve with a lower threshold
in URTI, has been demonstrated to capsaicin challenge
[9,10]. Recovery of the cough reflex to a more normal
level is seen as the infection abates. I suggest that cough
reflex hypersensitivity induced by virus is a fundamental
part of the pathogenesis of URTI enabling the viruses to
disseminate themselves through the population using
droplet transmission. A similar mechanism for manual
transmission exists in the coryza so characteristic of
human cough/cold. Experimental studies done by Tyrrel
in the Common Cold Research Unit in the 1950s clearly
demonstrate this as the major mechanism of viral trans-
mission [11].
Whether these observations of afferent neuronal hyper-
sensitivity are relevant to subjects with a chronic cough
have been difficult to prove with certainty and still cause
manifest confusion in the minds of clinicians and in the
published literature. The reason for this lack of clarity is
that unlike the bronchial hyperresponsiveness seen in the
asthmatic population where increased bronchomotor tone
is reflected in bronchoconstriction to, for example
methacholine, cough reflex hypersensitivity as manifest by
increased response to capsaicin or acid stimulus usually
still lies within the wide normal range. Thus, bronchial
hyperresponsiveness to methacholine is demonstrated
by shift in pc20 from a typical normal value of >16 mg/ml
to that below 4 mg/ml. In capsaicin responsiveness and
individual subject may show a C5 response of 1 micro-
molar capsaicin, which for them corresponds to
hyperresponsiveness but this value is well within the
normal range seen in the general population. This indi-
vidual’s normal value may be 30 micromolar and this is
only revealed by the successful treatment of their
chronic cough. Cough hypersensitivity is thereforeunreliable as a test of abnormality for an individual
patient. Cough hypersensitivity can be revealed in pop-
ulations as illustrated in Figure 1 [12]. A shift in the
capsaicin sensitivity induced by ACE inhibitors is seen
but the overwhelming majority of individuals remain
within the broad population normal range. Thus, in the
clinic there is very limited utility in performing cough
challenge to demonstrate cough hypersensitivity since
it is of no value in diagnosis and is only roughly corre-
lated with the clinical perception of cough.
Epidemiological evidence
The association of cough hypersensitivity with clinically
important chronic cough is perhaps best illustrated by
the epidemiological evidence of cough hypersensitivity
in the sexes. Several studies show that women have
heightened cough reflex to inhalation challenge with
capsaicin, citric acid, and tartaric acid [13,14]. However
this finding is not universal. For example we have
recently analysed a population of normal volunteers 39
males mean age 31 and 63 females mean age 37 and
found a near doubling of cough evoked by inhalation of
500 mM citric acid (Figure 2). Whereas in a similar
volunteer pool of 54 females, mean age 34 and 46 males,
mean age 31 there was no significant difference found in
capsaicin dose response with C2 (11 and 15 uM) and C5
(39 and 66 uM) values respectively being similar be-
tween the sexes. Given the previously described wide
range in cough sensitivity then large numbers are
required to detect any significant population differences
with certainty.
This female hypersensitivity appears to occur after pu-
berty, since girls and boys have the same reflex sensitivity
[15,16]. It has been suggested that cough hypersensitivity
in women is an evolutionary mechanism to protect against
aspiration during pregnancy. Preliminary evidence from
functional magnetic imaging studies suggests that cough













Gender and cough response to 500 
mM citric acid
* p<0.001
Figure 2 Mean cough response to citric acid in men vs women.
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cough reflex sensitivity is reflected in the population
attending cough clinics. In a demographic survey of over
5000 presentations with chronic cough to specialist
services women attended twice as frequently as men, with
a peak age of presentation in the 5th and 6th decade. Here
women also have a heightened cough reflex sensitivity to
capsaicin compared to men [17].
Mechanism of cough hypersensitivity
The mechanism whereby the hypersensitivity state within
the upper airways is produced is currently unknown.
Several possible mechanisms have been hypothesised. A
central response may well underlie the sex related differ-
ence to cause of the female preponderance. However, it is
unlikely to explain the local effects seen in airway disease.
Thus, patients with eosinophilic bronchitis appears to
have a particular form of mast cell infiltration associated
with airway nerves [18]. In contrast, in classic asthma the
same infiltrate is distributed within the airway smooth
muscle. Thus, targeting of inflammation to particular air-
way structures may be responsible for some of the differ-
ent phenotypes seen within the spectrum of asthmatic
cough. The distribution of nerves may well be altered by
disease. In a careful biopsy study Groneberg et al [19]
showed that there was an increase in TRPV1 containing
subepithelial sensory nerves within the bronchial wall
of chronic cough patients. However, Mitchell et al [20]
did not find this. Sampling error is bound to be an im-
portant factor in studies of small numbers in what is a
highly variable autonomic system in human lung. That
proinflammatory mediators can induce TRP receptor
function has been demonstrated in primary human
lung cell culture [21].
Within the vagus nerve various mechanisms of hyper-
sensitivity have been established, including that induced
by prostaglandins, particular PGE2 [22]. In the nodose
and jugular ganglia work from John’s Hopkins has dem-
onstrated that a distinct subset of neurones mediate the
cough response [23] and these may be responsible of
some manifestations of cough hypersensitivity.Pathogenesis of cough hypersensitivity
It is clear that a wide range of different insults may lead to
the inflammation and epithelial damage required to pro-
duce afferent sensory hypersensitivity of the upper air-
ways. Simple thermal or toxic damage induced by, for
example smoke inhalation or exposure to extreme cold
dry air is responsible for a number of clinical scenarios.
Human models of this are produced in the industrial
setting. Thus, exposure to hot acidic gas in bottle manu-
facturing leads to an increase in cough reflex hypersensi-
tivity and an increase of cough related symptoms [24].
Locally the factory was known as the ‘asthma factory’,
although investigation revealed cough hypersensitivity
rather than bronchial hyperresponsiveness.
A major and much overlooked cause of cough hyper-
sensitivity is gaseous non acid reflux. Because of the lack
of associated classic reflux symptoms of heartburn and
regurgitation this form of reflux, although described over
150 years ago as causing typical upper respiratory symp-
toms [25] has been largely missed. A questionnaire
(HARQ) has been developed to determine the associated
features of reflux induced cough [26]. Because of the
lack of classic symptoms the syndrome has been entitled
‘silent reflux’ by the ENT surgeons since there is associ-
ated loss of voice [27]. However, it is perhaps not an
appropriate term for a syndrome causing cough. Because
of the lack of acid, conventional oesophageal studies,
such as 24 hour pH monitoring are uninformative. The
single most useful investigation is high resolution man-
ometry, which provides information as to the underlying
neuromechanical defect of oesophageal function leading
to excessive gaseous reflux [28].Cough hypersensitivity as a disease
The paradigm shift from regarding cough as a symptom
of various diseases into cough as a disease with different
facets allows for a number of advantages in both diagno-
sis and therapy of this condition.
Firstly, the idea of cough hypersensitivity as the disease
removes the necessity to have a subgroup of chronic
coughers who have idiopathic cough. The patient does
have a disease; it is just that its origin may be mysterious.
If a considerable portion of patients with cough hypersen-
sitivity have occult airway reflux then the degree of cer-
tainty for individual clinicians is dependent on their
acceptance of the strength of evidence supporting the
diagnosis. Thus, the author would place many patients in
the category of cough hypersensitivity syndrome second-
ary to airway reflux whereas others, who have less agree-
ment with this as an aetiological mechanism, would place
more patients in cough hypersensitivity syndrome of
unknown aetiology. Cough hypersensitivity syndrome is
thus a unifying concept allowing differing opinions to
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pathobiological basis of the illness.
The second great strength of cough hypersensitivity as
a diagnosis is that by concentrating on a unifying patho-
logical feature it points the way to possible therapeutic
avenues which would not otherwise be revealed.
Thirdly, communicating with the patient is facilitated by
the diagnosis of the cough hypersensitivity syndrome.
Many patients in the clinic express their extreme frustra-
tion in the lack of understanding and the lack of a firm
diagnosis provided by the profession [29]. By giving the
syndrome a name and understanding the distinct epi-
demiological features outlined above allows the physician
to communicate our understanding of what is known
about the condition. Too often an isolated chronic cough
is dismissed as psychogenic or worse, when objective
cough counting clearly demonstrates the extreme fre-
quency of coughing paroxysms and explains the great dis-
tress suffered by the patient [30].
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